PRESENCE DU RECEPTEUR LIBRE AU RETINOL (cRBP) ET DU RECEPTRUR A L'ACIDE RETINOIQUE (cRABP) DANS LES TUMEURS CUTANEES HUMAINES

Translated title of the contribution: Retinoic-acid protein and free retinol-binding protein in human skin tumours.

J. C. Delarue, M. F. Avril, M. Prade, J. Y. Petit

Research output: Contribution to journalArticle

Abstract

The concentrations of cellular retinoic acid binding protein (cRABP) and free cellular retinol binding protein (cRBP) were determined by ultracentrifugation in sucrose gradient in the cytosol of 41 human skin tumours (14 melanomas, 19 basal cell carcinomas, 8 squamous cell carcinomas). cRBP was found respectively in 36%, 42% and 37% of the studied samples. On the contrary, cRABP was more frequently found in carcinomas (89% in basal cell carcinomas and 100% in squamous cell carcinomas) than in melanomas (21%) (p

Original languageFrench
Pages (from-to)193-200
Number of pages8
JournalBulletin du Cancer
Volume73
Issue number2
Publication statusPublished - 1986

Fingerprint

Cellular Retinol-Binding Proteins
Retinol-Binding Proteins
Retinoic Acid Receptors
Basal Cell Carcinoma
Tretinoin
Squamous Cell Carcinoma
Melanoma
Skin
Ultracentrifugation
Cytosol
Sucrose
Neoplasms
Proteins
Carcinoma

ASJC Scopus subject areas

  • Oncology

Cite this

PRESENCE DU RECEPTEUR LIBRE AU RETINOL (cRBP) ET DU RECEPTRUR A L'ACIDE RETINOIQUE (cRABP) DANS LES TUMEURS CUTANEES HUMAINES. / Delarue, J. C.; Avril, M. F.; Prade, M.; Petit, J. Y.

In: Bulletin du Cancer, Vol. 73, No. 2, 1986, p. 193-200.

Research output: Contribution to journalArticle

@article{669a78a51802406a998ae2442eb15b2b,
title = "PRESENCE DU RECEPTEUR LIBRE AU RETINOL (cRBP) ET DU RECEPTRUR A L'ACIDE RETINOIQUE (cRABP) DANS LES TUMEURS CUTANEES HUMAINES",
abstract = "The concentrations of cellular retinoic acid binding protein (cRABP) and free cellular retinol binding protein (cRBP) were determined by ultracentrifugation in sucrose gradient in the cytosol of 41 human skin tumours (14 melanomas, 19 basal cell carcinomas, 8 squamous cell carcinomas). cRBP was found respectively in 36{\%}, 42{\%} and 37{\%} of the studied samples. On the contrary, cRABP was more frequently found in carcinomas (89{\%} in basal cell carcinomas and 100{\%} in squamous cell carcinomas) than in melanomas (21{\%}) (p",
author = "Delarue, {J. C.} and Avril, {M. F.} and M. Prade and Petit, {J. Y.}",
year = "1986",
language = "Francese",
volume = "73",
pages = "193--200",
journal = "Bulletin du Cancer",
issn = "0007-4551",
publisher = "John Libbey Eurotext",
number = "2",

}

TY - JOUR

T1 - PRESENCE DU RECEPTEUR LIBRE AU RETINOL (cRBP) ET DU RECEPTRUR A L'ACIDE RETINOIQUE (cRABP) DANS LES TUMEURS CUTANEES HUMAINES

AU - Delarue, J. C.

AU - Avril, M. F.

AU - Prade, M.

AU - Petit, J. Y.

PY - 1986

Y1 - 1986

N2 - The concentrations of cellular retinoic acid binding protein (cRABP) and free cellular retinol binding protein (cRBP) were determined by ultracentrifugation in sucrose gradient in the cytosol of 41 human skin tumours (14 melanomas, 19 basal cell carcinomas, 8 squamous cell carcinomas). cRBP was found respectively in 36%, 42% and 37% of the studied samples. On the contrary, cRABP was more frequently found in carcinomas (89% in basal cell carcinomas and 100% in squamous cell carcinomas) than in melanomas (21%) (p

AB - The concentrations of cellular retinoic acid binding protein (cRABP) and free cellular retinol binding protein (cRBP) were determined by ultracentrifugation in sucrose gradient in the cytosol of 41 human skin tumours (14 melanomas, 19 basal cell carcinomas, 8 squamous cell carcinomas). cRBP was found respectively in 36%, 42% and 37% of the studied samples. On the contrary, cRABP was more frequently found in carcinomas (89% in basal cell carcinomas and 100% in squamous cell carcinomas) than in melanomas (21%) (p

UR - http://www.scopus.com/inward/record.url?scp=0022523499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022523499&partnerID=8YFLogxK

M3 - Articolo

C2 - 3015290

AN - SCOPUS:0022523499

VL - 73

SP - 193

EP - 200

JO - Bulletin du Cancer

JF - Bulletin du Cancer

SN - 0007-4551

IS - 2

ER -